Borroni, R. G. (2021) “Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study”, Acta Dermato-Venereologica, 101(11), p. adv00605. doi: 10.2340/actadv.v101.283.